<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>18</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Association of Some Polymorphisms in the VDR Gene, CYP17 Gene and SRD5A2 Gene and Prostate Cancer among Lebanese Men</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>93</FirstPage>
			<LastPage>100</LastPage>
			<ELocationID EIdType="pii">43109</ELocationID>
			
<ELocationID EIdType="doi">10.22034/APJCP.2017.18.1.93</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Asmahan </FirstName>
					<LastName>El Ezzi</LastName>

						<AffiliationInfo>
						<Affiliation>Lebanese Atomic Energy Commission, Beirut, Lebanon</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation> Department of Biochemistry, Lebanese University, Hadath, Lebanon</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation> Department of Chemistry, Utah Valley University, Orem, UT, USA.</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Vladyslav G </FirstName>
					<LastName>Boyko</LastName>
<Affiliation>Department of Biology, Utah Valley University, Orem, UT, USA</Affiliation>

</Author>
<Author>
					<FirstName>Monika </FirstName>
					<LastName>Baker</LastName>
<Affiliation>Department of Biology, Utah Valley University, Orem, UT, USA</Affiliation>

</Author>
<Author>
					<FirstName>Wissam R</FirstName>
					<LastName>Zaidan</LastName>
<Affiliation>Lebanese Atomic Energy Commission, Beirut, Lebanon</Affiliation>

</Author>
<Author>
					<FirstName>Kalim M</FirstName>
					<LastName>Hraiki</LastName>
<Affiliation>Department of Urology, Al-Salam Hospital, Tripoli, Lebanon</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad A</FirstName>
					<LastName>El-Saidi</LastName>
<Affiliation>Office of Academic Research Support, Utah Valley University, Orem, Utah, USA</Affiliation>

</Author>
<Author>
					<FirstName>Ruhul </FirstName>
					<LastName>Kuddus</LastName>
<Affiliation>Department of Biology, Utah Valley University, Orem, UT, USA</Affiliation>
<Identifier Source="ORCID">0000-0003-0697-1628</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>10</Month>
					<Day>21</Day>
				</PubDate>
			</History>
		<Abstract>Aims: The goal of the study was to investigate possible association of some single nucleotide polymorphisms&lt;br /&gt;(SNPs) in the VDR gene (the FokI, BsmI, ApaI and TaqαI loci), and the CYP17 gene (the MspA1I locus), and 0 or 9&lt;br /&gt;TA repeats in the SRD5A2 gene, and prostate cancer (PCa) among Lebanese men. Materials and Methods: Blood&lt;br /&gt;DNA of 69 subjects with confirmed PCa and 69 controls, all about 50 years of age or older, was subjected to PCR or&lt;br /&gt;PCR-restriction fragment-length polymorphism (PCR-RFLP) analyses, and the risk-bearing and the protective alleles&lt;br /&gt;were identified. The odds ratio (OR) of having a genotype and the relative risk (RR) of developing PCa were calculated.&lt;br /&gt;In addition, the distributions of homozygosis and heterozygosis in the risk-bearing alleles and the protective alleles&lt;br /&gt;among the control and the PCa groups were compared. Results: The f allele of the VDR FokI locus and the (TA) 9&lt;br /&gt;repeat allele of the SRD5A2 gene were found to be associated with increased risks of PCa (p = 0.006 and 0.050,&lt;br /&gt;respectively). Homozygosis in the risk-bearing alleles was rare both in the control and the PCa groups. A higher&lt;br /&gt;fraction of the controls compared to the PCa group was double-homozygous in the two protective alleles (52.2% for&lt;br /&gt;controls, 24.6% for PCa group, p = &lt;0.001). Conclusions: To the best of our knowledge, this is the first genetic study&lt;br /&gt;demonstrating the association of certain polymorphisms of the VDR gene and the SDR5A2 gene and increased risk of&lt;br /&gt;PCa among Lebanese men. Our study also indicates that the overall polymorphism profile of all genes involved in&lt;br /&gt;the prostate physiology is likely to be a better indicator for PCa risk than the polymorphisms in the individual genes.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Prostate cancer (PCa)- single nucleotide polymorphism (SNP)- TA repeat polymorphism- VDR gene</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_43109_c4bd43f730dab08288a87be2ce4b1b92.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
